Last reviewed · How we verify

NCT05504629

Interindividual Postexercise Hypotension Response in Morbid Obesity

Completed NA Last updated 24 August 2022
What this trial tests

NA trial testing Concurrent training order 1 in Metabolic Syndrome in 40 participants. Completed in 5 October 2019.

Timeline
5 March 2019
Primary endpoint
5 September 2019
5 October 2019

Quick facts

Lead sponsorUniversidad Nacional Andres Bello
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment40
Start date5 March 2019
Primary completion5 September 2019
Estimated completion5 October 2019
Sites1 location across Chile

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Nacional Andres Bello

Who can join

Adults 18 to 59, any sex, with Metabolic Syndrome or Morbid Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A quasi-experimental study developed in sedentary morbidly obese men and women (age 43.6±11.3 y; body mass index \[BMI\] ≥40 kg/m2) were assigned to a CT group of ET plus RT (ET+RT; n=19; BMI 47.8±16.7) or RT plus ET order group (RT+ET; n=17; BMI 43.0±8.0). Subjects of both groups received eight exercise sessions over four weeks. Systolic (SBP), diastolic (DBP), mean arterial pressure \[MAP\], heart rate at rest \[HR\], and pulse pressure \[PP\] measurements before and after 10 minutes postexercise. Secondary outcomes were other anthropometric, body composition, metabolic, and physical condition parameters. Using the ∆SBP reduction, and quartile categorization (Q) in 'high' (Rs: quartile 4), 'moderate' (MRs: quartile 3), 'low' (LRs: quartile 2), and 'nonresponders' (NRs: quartile 1) were reported.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Characterizing the interindividual postexercise hypotension response for two order groups of concurrent training in patients with morbid obesity.
    Álvarez C, Guede-Rojas F, Ramírez-Campillo R, Andrade DC, et al · · 2022 · cited 4× · PMID 36299263 · DOI 10.3389/fphys.2022.913645

Verify or expand the search:

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

Other Universidad Nacional Andres Bello trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05504629.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing